Inion review exceeds expectations with steady results
This article was originally published in Clinica
Executive Summary
Biodegradable orthopaedic implants specialist Inion has said the execution of its strategic review plan to improve its financial performances is exceeding expectations, as reflected in E2.3m ($3.2m) sales recorded in the first half of 2007, E300,000 ahead of analysts' expectations.